China is surpassing US in innovation；Patent grants up 10% at IP5

编辑制作：China IP 国际部

录音：李秀琴

Overview

一周概览

Focus

1. ITIF Report: China is overtaking the United States in innovation capacity

ITIF报告：中国的创新能力正在超越美国

2. Patent grants up 10% at IP5 offices in 2021

2021年世界五大专利局专利授权量增长10%

3. South Korea's international patent applications rose by 6.8% last year

韩国去年国际专利申请量同比增加6.8%

4. Nokia and Samsung Sign New 5G Patent License Agreement

诺基亚与三星签署了新的5G专利许可协议

IP Practice

5. GE to pay $60,000 per megawatt to Siemens Gamesa for its infringing turbines

通用电气涡轮机侵权，须向西门子歌美飒支付每兆瓦6万美元的费率

6. Nike sues Lululemon for infringement of footwear patents

耐克起诉露露柠檬侵犯其鞋类专利

7. Amazon EU faces fine of up to 10% of its turnover for misleading consumers

亚马逊欧洲部门因误导消费者而面临高达其营业额10%的罚款

8. Boston Scientific hit with $42 million for infringing coronary stents patents

波士顿科学因侵犯冠状动脉支架专利被判赔4200万美元

Case Analysis

9. Luxottica Group SpA v. Shenzhen Aisimo Trading Co., Ltd.

“雷朋”商标侵权纠纷案

Focus

1

ITIF Report: China is overtaking the United States in innovation capacity

ITIF报告：中国的创新能力正在超越美国

On January 23, the Information Technology & Innovation Foundation (ITIF) published a report entitled “Wake Up, America: China is Overtaking the United States in Innovation Output”, which applies innovation and industrial performance metrics for comparing relative innovation outputs from foreign technological rivals China and the United States. The report concludes that China is close to surpassing the United States in terms of innovation output per capita and calls upon U.S. policymakers to develop a national economic and technology policy to restore U.S. dominance in innovation.

1月23日，信息技术与创新基金会（ITIF）发表了一份题为《醒醒，美国：中国在创新能力上正在超过美国》的报告，该报告运用创新和工业绩效指标来比较来自外国技术竞争对手中国和美国的相对创新产出。报告称中国人均创新产出即将超过美国，并呼吁美国政策制定者制定国家经济和技术政策，以恢复美国在创新方面的主导地位。

2

Patent grants up 10% at IP5 offices in 2021

2021年世界五大专利局专利授权量增长10%

According to news released on the EPO official website, the world's five largest IP offices (IP5) have published the IP5 Statistics Report 2021 on the IP5 website. According to the report, in 2021, the IP5 granted 1.5 million patents, an increase of 10% on the previous year, and received 2.9 million patent applications (+3.7%). The IP5 Statistics Report 2021 confirms that demand for patents grew markedly in 2021 at the EPO, which received 188,600 European patent applications, up 4.5% on 2020. In addition, the EPO granted some 108,800 European patents last year.

欧专局（EPO）官网消息，世界五大知识产权局（IP5）近日在IP5网站上发布了2021年IP5统计报告。报告显示，2021年，IP5授予专利150万项，较上年增长10%，收到290万项专利申请，较上年增长3.7%。报告同时证实，2021年EPO的专利申请量显著增长，收到了188,600份欧洲专利申请，比2020年增长了4.5%。此外，欧专局去年授予了约108,800项欧洲专利。

3

South Korea's international patent applications rose by 6.8% last year

韩国去年国际专利申请量同比增加6.8%

According to news by KIPO on January 30, International patents filed in Korea under the Patent Cooperation Treaty(PCT) last year rose by 6.8 percent to 21,916. Among them, international patent applications from small and medium-sized enterprises increased by 13.2 percent. At the same period, domestic applications decreased by 0.2 percent to 237,000. In terms of applicants, large enterprises (9.3 percent), foreigners (4 percent) and small and medium-sized enterprises (0.8 percent) all increased, while individual applications decreased by 13.6 percent. In terms of fields, patent applications for cutting-edge technologies such as semiconductors (18.3%), e-commerce (7.5%) and digital communications (5.8%) increased, while patent applications in civil engineering (-17.1%), masks and other consumer goods (-16.1%) decreased.

据韩国特许厅1月30日消息，去年韩国境内依据《专利合作条约》申请的国际专利同比增加6.8%，共计2.1916万件。其中，中小企业的国际专利申请量增加13.2%。同期，国内专利申请量减少0.2%，共23.7万件。按申请主体看，大企业（9.3%）、外国人（4%）和中小企业（0.8%）均有所增加，但个人申请减少13.6%。按技术领域看，半导体（18.3%）、电子商务（7.5%）、数字通信（5.8%）等尖端技术领域的专利申请增加；土木工程（-17.1%）、口罩等其他消费品（-16.1%）领域有所减少。

4

Nokia and Samsung Sign New 5G Patent License Agreement

诺基亚与三星签署了新的5G专利许可协议

Nokia and Samsung have decided to sign a new multi-year patent license agreement after the previous one expired at the end of last year. Nokia’s new cross-license patent agreement with Samsung was announced on January 23, 2023. The agreement will see Nokia’s inventions in 5G and other forward-thinking technologies shared with Samsung, with the company making royalty payments to Nokia in return as of January 1, 2023. According to the report, Nokia has an expansive patent portfolio, with reportedly over €130 billion invested in research and development since the turn of the millennium. Nokia also has more than 4,500 patent families centred around 5G, and has approximately 20,000 patent families in total.

1月23日，诺基亚宣布已与三星签署了一项新的专利许可协议。此前的专利许可协议于去年年底到期，双方近日达成了新的长达数年的专利交叉许可协议。根据该协议，诺基亚将与三星共享在5G和其他前瞻性技术方面的发明，而三星将从2023年1月1日起向诺基亚支付专利使用费。据悉，诺基亚拥有广泛的专利组合，自世纪之交以来，已有超过1300亿欧元投资于研发。此外，诺基亚拥有超过4500个以5G为中心的专利家族，总共拥有约2万个专利家族。

IP Practice

5

GE to pay $60,000 per megawatt to Siemens Gamesa for its infringing turbines

通用电气涡轮机侵权，须向西门子歌美飒支付每兆瓦6万美元的费率

General Electric Co must double its patent royalty payments to Siemens Gamesa Renewable Energy, a Boston federal judge said Thursday. GE was ordered to pay $60,000 for each megawatt of capacity of its infringing turbines to Siemens Gamesa, doubling a jury's earlier award. Siemens Gamesa sued GE for patent infringement in Massachusetts in 2020 over GE's Haliade-X turbines. A jury had awarded Siemens Gamesa a royalty rate of $30,000 per megawatt. Siemens Gamesa asked the court to triple the rate for the New Jersey project to $90,000 for total damages of $109.3 million, arguing the court had allowed the projects to continue.

波士顿一名联邦法官周四表示，通用电气向西门子歌美飒支付的专利使用费需翻倍。通用电气需为侵犯西门子歌美飒专利的风力涡轮机支付每兆瓦6万美元的费用，是陪审团此前裁决赔偿额的两倍。2020年，西门子歌美飒在马萨诸塞州起诉通用电气的Haliade-X涡轮机侵犯了其专利，陪审团判给其每兆瓦3万美元的专利授权费。西门子歌美飒对此表示，鉴于法院允许通用电气继续在新泽西州的项目中使用侵权涡轮机，要求法院将授权费率提高至每兆瓦9万美元，赔偿总额为1.093亿美元。

相关阅读：

https://mp.weixin.qq.com/s/N_CNKZt5IZGBzG5cfYmfOA

6

Nike sues Lululemon for infringement of footwear patents

耐克起诉露露柠檬侵犯其鞋类专利

Nike Inc sued Lululemon Athletica Inc on Monday, saying that at least four of the Canadian athletic apparel company's footwear products infringe its patents. Nike said in a complaint filed in Manhattan federal court that it has suffered economic harm and irreparable injury from Lululemon's sale of its Blissfeel, Chargefeel Low, Chargefeel Mid and Strongfeel footwear. Nike said its three patents at issue concern textile and other elements, including one addressing how the footwear will perform when force is applied. Nike is seeking unspecified damages. Lululemon did not immediately respond to requests for comment.

本周一，耐克公司起诉了加拿大运动服装公司露露柠檬，称露露柠檬的至少4种鞋类产品侵犯了其专利。耐克在向曼哈顿联邦法院提起的诉讼中表示，露露柠檬出售其Blissfeel, Chargefeel Low, Chargefeel Mid 及Strongfeel运动鞋，给其造成了经济损失和无法挽回的伤害。耐克表示，其三项争议专利涉及纺织品和其他元素，其中一项专利涉及鞋子在受力时的表现。耐克要求未明确数额的损害赔偿。露露柠檬没有立即回应置评请求。

7

Amazon EU faces fine of up to 10% of its turnover for misleading consumers

亚马逊欧洲部门因误导消费者而面临高达其营业额10%的罚款

Poland's competition watchdog has accused e-commerce giant Amazon's European arm of misleading sales and delivery practices, the Office of Competition and Consumer Protection said on Wednesday. The office said consumers on Amazon's Polish website were misled as to the moment a sales contract is concluded, product availability, delivery times and consumer rights, which if proven could result in a penalty for Amazon EU of up to 10% of its turnover.

波兰竞争和消费者保护办公室周三表示，电子商务巨头亚马逊的欧洲部门具有误导销售及交付等行为。该竞争监管机构表示，亚马逊波兰网站上的消费者在签订销售合同的时间、产品供给量、交货时间和消费者权利方面均被误导。如果上述指控被证实，亚马逊欧洲部门可面临高达其营业额10%的罚款。

8

Boston Scientific hit with $42 million for infringing coronary stents patents

波士顿科学因侵犯冠状动脉支架专利被判赔4200万美元

According to news on Feb 1, TissueGen and the University of Texas won the jury verdict in a five-year legal battle against global leading medical devices manufacturer Boston Scientific. A federal jury in Delaware found that Boston Scientific infringed on a patent related to coronary stents held by the University of Texas and exclusively licensed to TissueGen and must pay $42 million in damages to the two plaintiffs. The jury determined that $42 million represents the royalties TissueGen should have collected from the stents, according to a verdict form.

2月1日消息，TissueGen和德克萨斯大学在与全球领先医疗器械制造商波士顿科学公司赢得了陪审团的裁决。双方的纠纷已持续了五年。特拉华州的一个联邦陪审团裁定，波士顿科学侵犯了一项由德克萨斯大学持有、独家授权给TissueGen的冠状动脉支架的相关专利。波士顿科学需向两原告支付4200万美元的损害赔偿。根据一份判决书，陪审团裁定，4200万美元是TissueGen本应获得的专利授权费。

Case Analysis

9

Luxottica Group SpA v. Shenzhen Aisimo Trading Co., Ltd.

“雷朋”商标侵权纠纷案

The authorized distributor did not follow the right holder's formal purchase process and purchased the goods at a lower price from factories selling products collected from after-sales services. If the right holder identified that the products were not authorized by it, the distributor's defense of "legitimate source" could not be established and its above-mentioned behavior constituted trademark infringement. Staging "fictitious sales" is a dishonest business behavior. The court should strictly review the evidence provided by the vendor. Only if the transaction records, payment vouchers, chat records and other evidence are sufficient to form a closed-loop chain and can corroborate each other, the relevant sales quantity could be excluded.

授权经销商未遵循权利人的正规进货流程，购进与正当进货方式不同、价格也较低的工厂“售后服务单”进行销售，在权利人鉴定不属于其授权产品的情形下，经销商的“合法来源”抗辩不能成立，其上述行为构成商标侵权。“刷单”属不诚信经营行为，法院对销售商提供的“刷单”证据应当严格审核，只有在交易记录、付款凭证、聊天记录等证据足以形成闭环链条且可以相互印证的情况下，方可对该部分销售数量予以剔除。

*更多有关本案详情请点击标题链接

图源网络

编译：China IP 国际部

英文投稿及市场合作：

jane.jiang@chinaipmagazine.com

18911449529（微信同号）

《知产观察家》

一档全新的知识产权行业对话式新闻评论节目

破解拟上市企业商标管理维护与运营中的顽疾

点一下你会更好看耶